Clearance of psoriasis with low dose cyclosporin.-Reference-Cited by-同舟云学术

Clearance of psoriasis with low dose cyclosporin.

Published:1986-09-20 Issue:6549 Volume:293 Page:731-732
ISSN:0959-8138
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Griffiths C E,Powles A V,Leonard J N,Fry L,Baker B S,Valdimarsson H

Publisher

BMJ

Subject

General Earth and Planetary Sciences,General Environmental Science,General Engineering

Reference41 articles.

1. Fibrinolysis in huma"n malignant tumosurs;Peterson, H.I.; Kjartansson, I.; Kersan-Bengsten, K.B.; CM, Rudenstam; Zettergren, L.;Acta CkirScand,1973

2. Effect ofpasioe activator (urokinase), plamoin, and tdrombin on glycoprotein and collagenous components of basement membrane;Liotta, L.A.; Goldfarb, R.H.; Brnmdage, R.; Siega, G.P.; Terranova, V.; Garbisa, S.;CancerRes,1981

3. Proteolytic enzymes of normal and malignant cells;Quigley, J.P.,1979

4. Plasninogen activator content of human colon tumors and normal mucosae: separaton of enzymets and partial purification.jNCI;Corsanti, J.G.; Celik, C.; Camiolo, S.M.,1980

5. Fibrinolytic activity of humarn tumors as measured by the fibrin plate method;Clifton EiE, Grossi MD;Cancer,1955

Cited by 212 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The biological basis of disease recurrence in psoriasis;Italian Journal of Dermatology and Venereology;2023-08

2. Significance of cuproptosis- related genes in the diagnosis and classification of psoriasis;Frontiers in Molecular Biosciences;2023-04-07

3. Understanding psoriasis: the development of the immune pathogenesis;Clinical and Experimental Dermatology;2022-11-01

4. From Empirical to Pathogenesis-Based Treatments for Psoriasis;Journal of Investigative Dermatology;2022-07

5. IL-23 Class of Biologic Agents in Psoriatic Disease;Updates in Clinical Dermatology;2022